Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-8-29
pubmed:abstractText
This study was performed to investigate whether a fraction of hydroxyethyl starch macromolecules, prepared from pentastarch and known as "Hes-Pz," with molecular weights of 100,000-1,000,000, protects against blood-brain barrier (BBB) disruption due to intracarotid injection of hyperosmolar mannitol. Rats were anesthetized with isoflurane, and retrograde catheterization of a unilateral eternal carotid artery was performed. Except for the Control group (n = 8), hemodilution was performed using lactated Ringer's solution LR group, n = 7), 6% hetastarch (HES group, n = 7), or 6% HES-Pz (HES-Pz group, n = 8) to reduce the hematocrit to about 23%. The BBB transfer coefficient (Ki) of 14C-alpha-aminoisobutyric acid was determined after a unilateral intracarotid injection of 25% mannitol. Blood pressure and hematocrit were similar in all groups. In the control group, Ki was increased significantly in the ipsilateral cortex (IC) where mannitol was injected (16.3 +/- 6.1 vs 4.1 +/- 1.4 microL.min-1) when compared with the contralateral cortex (CC). Ki was similar in the CC in all four groups. The Ki in the IC was significantly lower in the HES-Pz(6.4 +/- 3.5 microL.g-1.min-1) than in the Control, HES, or LR group (16.3 +/- 6.1, 19.0 +/- 12.9, 17.9 +/- 10.8 microL.g-1.min-1, respectively). Our data suggest that HES-Pz significantly attenuates disruption of the BBB caused by an injection of hyperosmolar mannitol.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0003-2999
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
336-41
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8694315-Aminoisobutyric Acids, pubmed-meshheading:8694315-Animals, pubmed-meshheading:8694315-Blood Pressure, pubmed-meshheading:8694315-Blood-Brain Barrier, pubmed-meshheading:8694315-Carbon Radioisotopes, pubmed-meshheading:8694315-Carotid Arteries, pubmed-meshheading:8694315-Cerebral Cortex, pubmed-meshheading:8694315-Diuretics, Osmotic, pubmed-meshheading:8694315-Hematocrit, pubmed-meshheading:8694315-Hemodilution, pubmed-meshheading:8694315-Hetastarch, pubmed-meshheading:8694315-Injections, Intra-Arterial, pubmed-meshheading:8694315-Isotonic Solutions, pubmed-meshheading:8694315-Macromolecular Substances, pubmed-meshheading:8694315-Male, pubmed-meshheading:8694315-Mannitol, pubmed-meshheading:8694315-Molecular Weight, pubmed-meshheading:8694315-Osmolar Concentration, pubmed-meshheading:8694315-Plasma Substitutes, pubmed-meshheading:8694315-Rats
pubmed:year
1996
pubmed:articleTitle
Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
pubmed:affiliation
Department of Anesthesia, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901-1977, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't